Early-onset diabetes may raise risk of dementia-related disease
Published:
Tags:
Researchers explore diabetes-dementia connection
WESTON, Fla. – Researchers are discovering that the early onset of Type II diabetes may increase the risk of various forms of dementia later in life.
Dr. Damon Salzman, a neurologist with Cleveland Clinic Weston said that over time, increased blood sugar appears to affect the brain’s ability to function well.
“In addition, untreated diabetes, especially Type II diabetes, may also increase the risk of atherosclerosis or thickening of the blood vessels and this can also impede perfusion to the brain,” he said
Salzman said the study found the risk of dementia-type diseases increased 25% with early-onset diabetes.
/PRNewswire/ Cleveland Clinic s Weston Hospital has performed its first living donor liver transplant, in which a daughter donated a portion of her liver to.
March 19 marks world IBD Awareness Day local10.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from local10.com Daily Mail and Mail on Sunday newspapers.
Investigation into treatment for recurring small cell lung cancer
Published:
Tags:
Researchers looking into new treatment for lung cancer
WESTON, Fla. – Researchers with the National Institutes of Health are zoning in on a potential target for an aggressive and dangerous form of cancer.
Dr. Evan Alley, an oncologist with Cleveland Clinic Weston, said scientists found that combining an FDA approved chemotherapy drug called Topotecan with an investigational drug M6620 showed promising results in the treatment of recurring small cell lung cancer.
“In a small study of 25 patients, the response rate was 36 percent, which is very promising considering what we know with Topotecan alone,” Alley said.
Emerging research uncovers greater understanding of certain breast cancers
Published:
Tags:
WESTON, Fla. – An estimated 10% to 20% of breast cancers are known as “triple negative,” meaning they don’t respond to hormonal therapies and other medications.
While this can make triple negative breast cancer more deadly, Dr. Thomas Samuel, an oncologist with the Cleveland Clinic Weston, said a recent study found sub-types of the disease that respond differently to treatment.
“What this tells us is that if you have some of these certain sub-types, they may need less therapy than we would normally recommend. In other words, all triple negative breast cancers are not the same and they shouldn’t all be treated the same. There really should be a breakdown of what type of triple negative cancer it is and then tailor the treatment to that diagnosis,” he said.